Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

DUBLIN and CHICAGO, May 19, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV ...

Although the firm is bullish on Prothena Corporation plc (NASDAQ:PRTA), it reduced its price target after the company ...

The Retail-Wholesale group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Next PLC (NXGPY) is a stock that can certainly grab the ...

David Droga, CEO of creative group Accenture Song, will step down from his role in September, transitioning to a broader ...

Prothena Corporation plc's phase 3 trial failure in AL Amyloidosis was a setback, but Alzheimer's & Parkinson's data could ...

Prothena Corporation (NASDAQ:PRTA) is a clinical-stage neuroscience company that discovers and develops novel therapies for ...

Investors might want to bet on Next PLC (NXGPY), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

InterContinental Hotels Group PLC ( NYSE: IHG) shares have proved a solid investment over the past few years. The stock has ...

Over the next 12-18 months, Moody’s anticipates SIG’s EBITDA to increase by up to 20% due to increased volumes and margin improvements from the company’s restructuring and cost-saving initiatives.